Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Grace Goldstein"'
Autor:
Christina Darden, Mark Price, David Ray, Grace Goldstein, Diana Goss, Lee Bennett, Diana Garbinsky, Ramya Thota
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 5, Iss 1, Pp 1-10 (2021)
Abstract Background Long-acting somatostatin analogs (LA SSAs) are approved and recommended for the treatment of patients with advanced neuroendocrine tumors (NETs). Given the long duration of therapy and differences in administration routes, it is i
Externí odkaz:
https://doaj.org/article/7a5bb3f3059146f4bb5221529e84bf10
Autor:
Mohid S. Khan, Katharina Mellar, Rupert Watts, Isabelle Bocher-Pianka, Abdelali Majdi, Grace Goldstein
Publikováno v:
Oncology and Therapy, Vol 8, Iss 1, Pp 67-80 (2019)
Abstract Introduction Patient surveys of disease burden on daily living rarely explore the impact that patient information sources can have on optimizing care. Methods To identify unmet needs/possible solutions for information and support to address
Externí odkaz:
https://doaj.org/article/03d8216b9f314d2bb531c6e15ad530db
Autor:
Caroline, Seo, Erica, Horodniceanu, Rachel, Shah, Grace, Goldstein, David, Ray, Bonita, Bennett, Alexandria, Phan, Kelly, McCarrier
Publikováno v:
Supportive Care in Cancer. 30:6307-6316
Abstract Purpose Neuroendocrine tumors (NETs) negatively impact patients’ quality of life. Octreotide long-acting release (LAR) and lanreotide depot are somatostatin analogs (SSAs) approved to treat NETs. The study objective was to explore SSA trea
Autor:
Dermot O’Toole, Pamela L. Kunz, Susan M. Webb, Grace Goldstein, Sheila Khawaja, Mark McDonnell, Sandra Boiziau, Delphine Gueguen, Aude Houchard, Antonio Ribeiro-Oliveira, Ally Prebtani
Publikováno v:
Advances in therapy.
Real-world data evaluating patients' injection experiences using the latest devices/formulations of the long-acting (LA) somatostatin analogs (SSAs) lanreotide Autogel/Depot (LAN; Somatuline®) and octreotide LA release (OCT; Sandostatin®) are limit
Autor:
Teodora Kolarova, Martyn Caplin, George A. Fisher, Simone Leyden, Ben Lawrence, David C. Metz, Bertram Wiedenmann, Ronald Hollander, Siobhan Conroy, Phillipa Davies, Dermot O'Toole, Yoshiyuki Majima, Catherine Bouvier, Grace Goldstein, Sugandha Dureja, Massimo Falconi, Rodney J. Hicks, Philippe Ruszniewski, Piero Ferolla
Publikováno v:
International Journal of Cancer
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, pa
Autor:
Grace Goldstein, Alexandre Santos, Jean-Philippe Metges, Denis Smith, Côme Lepage, Edward M. Wolin, Ron Hollander, Rosine Guimbaud, Christine Do Cao, Philippe Ruszniewski, Eric Baudin, Catherine Lombard-Bohas
Publikováno v:
International Journal of Endocrine Oncology. 7
Background: There is a lack of knowledge regarding the experience of patients with neuroendocrine tumors (NET) in France. Materials & methods: A patient survey that captured information on diagnosis, disease impact/management and awareness was conduc
Autor:
Thorvardur Ragnar Halfdanarson, Diane Lauren Reidy, Namrata Vijayvergia, Daniel M. Halperin, Grace Goldstein, Grace Kong, Michael Michael, Simone Leyden, Simona Grozinsky-Glasberg, Halfdan Sorbye, Kjell E. Oberg, Cristina Sierras, Philip Harris
Publikováno v:
Journal of Clinical Oncology. 40:TPS514-TPS514
TPS514 Background: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs), which represent approximately 70% of NETs, frequently develop metastatic disease with limited treatment options. Current standard therapies for well-differentiated high grade
Autor:
Edward M. Wolin, Teodora Kolarova, Richard R.P. Warner, Ron Hollander, John Leyden, Grace Goldstein
Publikováno v:
Pancreas
Supplemental digital content is available in the text.
Objectives The aim of this survey was to examine the experience of patients with neuroendocrine tumors (NETs) to raise awareness of the NET-related burden and identify unmet needs. Here, we
Objectives The aim of this survey was to examine the experience of patients with neuroendocrine tumors (NETs) to raise awareness of the NET-related burden and identify unmet needs. Here, we
Autor:
Kjell Öberg, Marianne Pavel, John Leyden, Teodora Kolarova, Simron Singh, Maia Sissons, Grace Goldstein, Dan Granberg, Edward M. Wolin, Richard R.P. Warner
Publikováno v:
Journal of global oncology
Purpose Despite the considerable impact of neuroendocrine tumors (NETs) on patients’ daily lives, the journey of the patient with a NET has rarely been documented, with published data to date being limited to small qualitative studies. NETs are het
Autor:
Simone Leyden, Bertram Wiedenmann, Philippe Ruszniewski, Martyn E. Caplin, Siobhan Conroy, Piero Ferolla, Sugandha Dureja, Yoshiyuki Majima, Teodora Kolarova, Catherine Bouvier, Grace Goldstein, Ron Hollander, George A. Fisher, Rodney J. Hicks, Massimo Falconi, David C. Metz, Dermot O'Toole, Benjamin Lawrence, Philippa Davies
Publikováno v:
Journal of Global Oncology. 5:6-6
e13524 Background: The aim of this global patient survey was to better understand the needs and expectations of patients with NETs regarding access to diagnostic tools and treatment. Methods: In 2017, an online, questionnaire survey of NET patients/f